Liver histology and progression of fibrosis in individuals with chronic hepatitis C and persistently normal ALT.

PubWeight™: 1.63‹?› | Rank: Top 4%

🔗 View Article (PMID 12873583)

Published in Am J Gastroenterol on July 01, 2003

Authors

Ioannis Kyrlagkitsis1, Bernard Portmann, Heather Smith, John O'Grady, Matthew E Cramp

Author Affiliations

1: Institute of Liver Studies, King's College Hospital, London, United Kingdom.

Articles by these authors

HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science (2004) 8.22

Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med (2015) 3.47

Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis. Lancet (2014) 3.12

Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology (2004) 3.00

Providing treatment to prisoners with mental disorders: development of a policy. Selective literature review and expert consultation exercise. Br J Psychiatry (2003) 2.79

Prevalence of methicillin-resistant Staphylococcus aureus among staff and pets in a small animal referral hospital in the UK. J Antimicrob Chemother (2005) 2.38

Hereditary fibrinogen A alpha-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation. Blood (2009) 2.30

Non-travel-associated hepatitis E in England and Wales: demographic, clinical, and molecular epidemiological characteristics. J Infect Dis (2005) 2.18

Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol (2012) 2.15

Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mechanism. J Cell Physiol (2006) 2.13

Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl (2002) 2.00

Molecular characterization of meiotic recombination across the 140-kb multigenic a1-sh2 interval of maize. Proc Natl Acad Sci U S A (2002) 1.98

Increasing burden of liver disease in patients with HIV infection. Lancet (2011) 1.98

The MicroRNA let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes. J Biol Chem (2007) 1.90

Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut (2010) 1.83

Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Ann Intern Med (2013) 1.82

A critical review of the fluoroquinolones: focus on respiratory infections. Drugs (2002) 1.79

Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis--a randomised clinical trial. J Hepatol (2005) 1.79

Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology (2002) 1.77

Mucinous cystic neoplasms of the liver: a clinicopathological study and comparison with intraductal papillary neoplasms of the bile duct. Mod Pathol (2011) 1.74

Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database. J Hepatol (2012) 1.66

A novel monoclonal antibody to characterize pathogenic polymers in liver disease associated with alpha1-antitrypsin deficiency. Hepatology (2010) 1.62

Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus. Hepatology (2010) 1.59

Distinct microRNA profiles are associated with the severity of hepatitis C virus recurrence and acute cellular rejection after liver transplantation. Liver Transpl (2013) 1.48

Liver transplantation in human immunodeficiency virus-infected patients: procoagulant, but is antithrombotic prophylaxis required? Liver Transpl (2012) 1.45

Chronic liver disease related to 6-thioguanine in children with acute lymphoblastic leukaemia. J Hepatol (2005) 1.44

The biliary atresia splenic malformation syndrome: a 28-year single-center retrospective study. J Pediatr (2006) 1.42

Image of the month. Copper-metallothionein autofluorescence. Hepatology (2009) 1.39

Acute sickle cell hepatopathy represents a potential contraindication for percutaneous liver biopsy. Blood (2002) 1.34

Concordant exploration of the kinetics of RNA folding from global and local perspectives. J Mol Biol (2005) 1.33

Tethering by lamin A stabilizes and targets the ING1 tumour suppressor. Nat Cell Biol (2008) 1.31

Human plasma fibrinogen is synthesized in the liver. Blood (2006) 1.27

Spontaneous rupture of hepatocellular carcinoma: a Western experience. Am J Surg (2008) 1.25

Cyclotides: natural, circular plant peptides that possess significant activity against gastrointestinal nematode parasites of sheep. Biochemistry (2008) 1.18

The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study. J Hepatol (2007) 1.16

Acute liver failure associated with antiretroviral treatment for HIV: a report of six cases. J Hepatol (2002) 1.14

Liver transplantation for Budd-Chiari syndrome. Transplantation (2002) 1.12

Hepatitis C virus (HCV)--specific T cell responses in injection drug users with apparent resistance to HCV infection. J Infect Dis (2008) 1.12

Liver transplantation for HCV-related cirrhosis in a patient with gastric mucosa-associated lymphoma (MALToma) pretreated with rituximab. Liver Transpl (2005) 1.08

How we treat sickle hepatopathy and liver transplantation in adults. Blood (2014) 1.07

Fibroblast and lymphoblast gene expression profiles in schizophrenia: are non-neural cells informative? PLoS One (2008) 1.02

Mixed phenotype hepatocellular carcinoma after transarterial chemoembolization and liver transplantation. Liver Transpl (2011) 1.01

Molecular characterization of fluoroquinolone resistant Streptococcus pneumoniae clinical isolates obtained from across Canada. Diagn Microbiol Infect Dis (2003) 1.01

ING function in apoptosis in diverse model systems. Biochem Cell Biol (2009) 1.00

Immunosuppression minimization vs. complete drug withdrawal in liver transplantation. J Hepatol (2013) 0.99

Polymorphisms in the IL-12B gene and outcome of HCV infection. J Interferon Cytokine Res (2005) 0.98

CTGF disrupts alveolarization and induces pulmonary hypertension in neonatal mice: implication in the pathogenesis of severe bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol (2011) 0.97

Treatment of autoimmune hepatitis: a review of current and evolving therapies. J Gastroenterol Hepatol (2011) 0.96

Liver transplantation for Budd-Chiari syndrome: A European study on 248 patients from 51 centres. J Hepatol (2005) 0.96

Dose-response assay templates for in vitro assessment of resistance to benzimidazole and nicotinic acetylcholine receptor agonist drugs in human hookworms. Am J Trop Med Hyg (2009) 0.95

Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trial. Trials (2013) 0.95

Bile duct strictures after adult liver transplantation: a role for biliary reconstructive surgery? Liver Transpl (2004) 0.94

Synergism of tapasin and human leukocyte antigens in resolving hepatitis C virus infection. Hepatology (2013) 0.94

Hyporesponsiveness of murine B lymphocytes exposed to the filarial nematode secreted product ES-62 in vivo. Immunology (2003) 0.94

Identification of a pharmacophore for thrombopoietic activity of small, non-peptidyl molecules. 2. Rational design of naphtho[1,2-d]imidazole thrombopoietin mimics. J Med Chem (2002) 0.93

Single-center experience with liver transplantation from controlled non-heartbeating donors: a viable source of grafts. Ann Surg (2005) 0.93

King's Score: an accurate marker of cirrhosis in chronic hepatitis C. Eur J Gastroenterol Hepatol (2009) 0.92

HLA class I allelic diversity and progression of fibrosis in patients with chronic hepatitis C. Hepatology (2006) 0.92

Risk factors for methicillin-resistant Staphylococcus aureus (MRSA) infection in dogs and cats: a case-control study. Vet Res (2010) 0.91

Imatinib mesylate as a cause of acute liver failure. Am J Hematol (2006) 0.91

Identification of a pharmacophore for thrombopoietic activity of small, non-peptidyl molecules. 1. Discovery and optimization of salicylaldehyde thiosemicarbazone thrombopoietin mimics. J Med Chem (2002) 0.89

Liver disease in children with primary immunodeficiencies. J Pediatr (2004) 0.88

Two distinct pathways of carcinogenesis in primary sclerosing cholangitis. Histopathology (2011) 0.87

Acute hepatitis A virus infection: a review of prognostic factors from 25 years experience in a tertiary referral center. Hepatogastroenterology (2002) 0.87

Noninvasive markers of fibrosis and inflammation in clinical practice: prospective comparison with liver biopsy. Eur J Gastroenterol Hepatol (2010) 0.87

Follicular cholangitis and pancreatitis - clinicopathological features and differential diagnosis of an under-recognized entity. Histopathology (2012) 0.86

Simultaneous combined liver and kidney transplantation: a single center experience. Clin Transplant (2010) 0.86

Hepatocellular carcinoma in biliary atresia: King's College Hospital experience. J Pediatr (2011) 0.86

Risk and protective genetic variants in suicidal behaviour: association with SLC1A2, SLC1A3, 5-HTR1B &NTRK2 polymorphisms. Behav Brain Funct (2011) 0.85

Immunoglobulin G4-related sclerosing cholangitis: pathologic features and histologic mimics. Semin Diagn Pathol (2012) 0.85

Bisphosphonate-induced osteonecrosis of the jaw requires early detection and intervention. Med J Aust (2005) 0.84

Possible involvement of CCL1-CCR8 interaction in lymphocytic recruitment in IgG4-related sclerosing cholangitis. J Hepatol (2013) 0.84

Evaluation of the Rhodes Index of Nausea and Vomiting for ambulatory surgery patients. J Adv Nurs (2004) 0.84

Hepatic expression of IL-15 mRNA is associated with liver graft acceptance. Transpl Immunol (2003) 0.84

Cystic dystrophy in heterotopic pancreas: a rare indication for pancreaticoduodenectomy. Hepatobiliary Pancreat Dis Int (2009) 0.84

Pharmacodynamic activity of fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae. J Antimicrob Chemother (2002) 0.83

Strategy to reduce the risk of positive pancreatic resection margin at pancreatico-duodenectomy. ANZ J Surg (2008) 0.83

Medical and psychiatric outcomes for patients transplanted for acetaminophen-induced acute liver failure: a case-control study. Liver Int (2010) 0.83

Hepatocellular adenoma in glycogen storage disorder type I: a clinicopathological and molecular study. Histopathology (2012) 0.83

Proportion between wild-type and mutant protein in truncated compared to full-length ATTR: an analysis on transplanted transthyretin T60A amyloidosis patients. Biochem Biophys Res Commun (2008) 0.83

The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis. Liver Int (2011) 0.83

The cytoprotective effect of alpha-tocopherol and daidzein against d-galactosamine-induced oxidative damage in the rat liver. Metabolism (2007) 0.82

Liver transplantation in human immunodeficiency virus-positive patients. Liver Transpl (2011) 0.82

Management of delirium in critically ill older adults. Crit Care Nurse (2012) 0.82

Attempting to predict the unpredictable in acute liver injury. J Hepatol (2005) 0.81

Modelling the impact of improving screening and treatment of chronic hepatitis C virus infection on future hepatocellular carcinoma rates and liver-related mortality. BMC Gastroenterol (2014) 0.81

A study of molecular mimicry and immunological cross-reactivity between hepatitis B surface antigen and myelin mimics. Clin Dev Immunol (2005) 0.81

Immunoglobulin G4-positive plasma cell infiltration in explanted livers for primary sclerosing cholangitis. Histopathology (2011) 0.81

Treatment Acceptability Study of Walking The Middle Path, a New DBT Skills Module for Adolescents and their Families. Am J Psychother (2015) 0.80

Further experience with the use of 6-thioguanine in patients with Crohn's disease. Inflamm Bowel Dis (2008) 0.80

Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry. Prostate Cancer (2012) 0.80